Us Bancorp \De\ Ptc Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 7,409 shares of PTCT stock, worth $313,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,409

Previous 7,466 0.76%

Holding current value

$313,993

Previous $228,000 20.18%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$30.39 - $37.66 $1,732 - $2,146	-57 Reduced 0.76%	7,409 $274,000
Q2 2024 Aug 06, 2024	SELL	$24.69 - $40.12 $11,826 - $19,217	-479 Reduced 6.03%	7,466 $228,000
Q1 2024 May 07, 2024	SELL	$24.15 - $31.95 $11,978 - $15,847	-496 Reduced 5.88%	7,945 $231,000
Q4 2023 Feb 09, 2024	BUY	$18.07 - $29.37 $50,035 - $81,325	2,769 Added 48.82%	8,441 $232,000
Q3 2023 Nov 03, 2023	SELL	$22.41 - $41.99 $13,692 - $25,655	-611 Reduced 9.72%	5,672 $127,000
Q2 2023 Aug 09, 2023	SELL	$40.4 - $59.1 $85,769 - $125,469	-2,123 Reduced 25.26%	6,283 $255,000
Q1 2023 May 09, 2023	BUY	$38.16 - $48.86 $25,185 - $32,247	660 Added 8.52%	8,406 $407,000
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $18,072 - $29,531	-539 Reduced 6.51%	7,746 $295,000
Q3 2022 Oct 27, 2022	SELL	$41.85 - $53.85 $27,662 - $35,594	-661 Reduced 7.39%	8,285 $416,000
Q2 2022 Aug 01, 2022	SELL	$25.6 - $45.23 $7,961 - $14,066	-311 Reduced 3.36%	8,946 $359,000
Q1 2022 May 11, 2022	BUY	$33.33 - $44.6 $27,730 - $37,107	832 Added 9.88%	9,257 $345,000
Q4 2021 Feb 11, 2022	BUY	$35.36 - $41.86 $43,103 - $51,027	1,219 Added 16.92%	8,425 $336,000
Q3 2021 Nov 10, 2021	BUY	$37.01 - $44.74 $20,318 - $24,562	549 Added 8.25%	7,206 $268,000
Q2 2021 Aug 05, 2021	BUY	$37.95 - $49.37 $22,314 - $29,029	588 Added 9.69%	6,657 $281,000
Q1 2021 Apr 28, 2021	BUY	$46.8 - $68.92 $269,895 - $397,461	5,767 Added 1909.6%	6,069 $288,000
Q4 2020 Feb 04, 2021	BUY	$47.96 - $67.64 $10,359 - $14,610	216 Added 251.16%	302 $18,000
Q3 2020 Nov 10, 2020	BUY	$45.41 - $57.07 $2,633 - $3,310	58 Added 207.14%	86 $4,000
Q2 2020 Aug 07, 2020	BUY	$42.56 - $54.98 $1,191 - $1,539	28 New	28 $1,000
Q3 2019 Nov 08, 2019	SELL	$33.82 - $48.17 $64,528 - $91,908	-1,908 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$35.42 - $45.0 $42,751 - $54,315	-1,207 Reduced 38.75%	1,908 $86,000
Q1 2019 May 08, 2019	BUY	$28.09 - $39.49 $7,415 - $10,425	264 Added 9.26%	3,115 $117,000
Q4 2018 Feb 13, 2019	BUY	$29.83 - $46.51 $28,577 - $44,556	958 Added 50.61%	2,851 $98,000
Q3 2018 Nov 01, 2018	BUY	$33.9 - $47.77 $5,424 - $7,643	160 Added 9.23%	1,893 $89,000
Q2 2018 Aug 08, 2018	BUY	$25.7 - $47.88 $44,538 - $82,976	1,733 New	1,733 $58,000

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account